By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
DrugPatentWatch Database Preview
Msn - Profile
Email this page to a colleague
Drugs and US Patents for Msn
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Msn | TERIFLUNOMIDE | teriflunomide | TABLET;ORAL | 209623-002 | Apr 24, 2019 | DISCN | No | No | Get Started Free | Get Started Free | |||||
| Msn Pharms Inc | DROXIDOPA | droxidopa | CAPSULE;ORAL | 211741-001 | Feb 18, 2021 | AB | RX | No | No | Get Started Free | Get Started Free | ||||
| Msn | DEFERASIROX | deferasirox | TABLET, FOR SUSPENSION;ORAL | 209878-003 | Nov 20, 2019 | AB | RX | No | No | Get Started Free | Get Started Free | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
